Voyager Therapeutics, Inc.Voyager Therapeutics, Inc.Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

No trades
See on Supercharts

VYGR fundamentals

An in-depth look to Voyager Therapeutics, Inc. operating, investing, and financing activities

VYGR free cash flow for Q2 24 is -32.55 M USD. For 2023, VYGR free cash flow was 74.66 M USD and operating cash flow was 77.92 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth